Age-Related Macular Degeneration Drug Combo Scrapped Despite Safe Profile
December 11th 2018Zimura (avacincaptad pegol) was generally well tolerated when given to patients in combination with ranibizumab (Lucentis), but Ophthotech Corp announced it will focus efforts on other clinical programs.
Read More